Athna Biotech provides scientific and strategic consulting to support the translation of innovative therapeutics from early-stage research toward clinical development. Our team brings experience in nanomedicine, preclinical development, regulatory strategy, and IND-enabling activities to help researchers and emerging biotechnology companies advance promising technologies.

Our consulting services include:

• Preclinical Development Strategy – Guidance on efficacy, safety, pharmacology, and IND-enabling study planning.
• Nanomedicine & Formulation Development – Scientific guidance on formulation optimization, characterization, process development, and scale-up.
• Regulatory Strategy – Support for pre-IND planning, regulatory development strategy, and preparation for FDA interactions.
• Translational Development Planning – Identification of development gaps, key milestones, and next steps toward clinical translation.
• Grant & Development Strategy – Scientific guidance for SBIR/STTR and other translational funding opportunities.